Hospital Universitario Son Espases-ko ikertzaileekin lankidetzan egindako argitalpenak (54)

2024

  1. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine, Vol. 127, pp. 126-133

  2. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  3. Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis

    Leukemia

  4. Incremental value of C-reactive protein to the MEESSI acute heart failure risk score

    European Journal of Heart Failure, Vol. 26, Núm. 8, pp. 1749-1758

  5. Older Adult Patients in the Emergency Department: Which Patients should be Selected for a Different Approach?

    Annals of Geriatric Medicine and Research, Vol. 28, Núm. 1, pp. 9-19

  6. The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis

    American Journal of Hematology

2023

  1. Impact of the MEESSI-AHF tool to guide disposition decision-making in patients with acute heart failure in the emergency department: A before-and-after study

    Emergency Medicine Journal, Vol. 41, Núm. 1, pp. 42-50

  2. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 6, pp. 1759-1770.e7

  3. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 842-845

2022

  1. Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study

    Haematologica, Vol. 107, Núm. 11, pp. 2675-2684

  2. Prognosis of acute heart failure based on clinical data of congestion

    Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 321-331

  3. Short-term outcomes by chronic betablocker treatment in patients presenting to emergency departments with acute heart failure: BB-EAHFE

    European Heart Journal: Acute Cardiovascular Care, Vol. 11, Núm. 10, pp. 761-771

  4. Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update

    Archivos de Bronconeumologia, Vol. 58, Núm. 4, pp. 345-351

  5. Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome

    Archivos de Bronconeumologia, Vol. 58, Núm. 2, pp. 159-170

  6. Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 69-81

  7. The Clinical outcomes, healthcare resource utilization, and related costs (COHERENT) model. Application in heart failure patients

    Revista Espanola de Cardiologia, Vol. 75, Núm. 7, pp. 585-594

  8. [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care

    Archivos de Bronconeumologia, Vol. 58, Núm. 4, pp. T334-T344

2021

  1. Analysis of standards of quality for outcomes in acute heart failure patients directly discharged home from emergency departments and their relationship with the emergency department direct discharge rate

    Journal of Cardiology, Vol. 77, Núm. 3, pp. 245-253

  2. COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort

    Respiratory research, Vol. 22, Núm. 1, pp. 36

  3. Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry

    International Journal of Cardiology, Vol. 344, pp. 127-134